268 related articles for article (PubMed ID: 33703999)
1. Association between hyperandrogenism and adverse pregnancy outcomes in patients with different polycystic ovary syndrome phenotypes undergoing
Ma L; Cao Y; Ma Y; Zhai J
Gynecol Endocrinol; 2021 Aug; 37(8):694-701. PubMed ID: 33703999
[TBL] [Abstract][Full Text] [Related]
2. [Effect of hyperandrogenism on pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer].
Jiang LL; Pan P; Jiao XD; Qiu Q; Li Y; Zhang QX
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(14):1042-1048. PubMed ID: 37032154
[No Abstract] [Full Text] [Related]
3. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
[No Abstract] [Full Text] [Related]
4. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
[TBL] [Abstract][Full Text] [Related]
5. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
Kadoura S; Alhalabi M; Nattouf AH
Sci Rep; 2022 Mar; 12(1):4456. PubMed ID: 35292717
[TBL] [Abstract][Full Text] [Related]
6. Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials.
Palomba S; Falbo A; La Sala GB
BJOG; 2013 Feb; 120(3):267-76. PubMed ID: 23194199
[TBL] [Abstract][Full Text] [Related]
7. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
Siristatidis CS; Maheshwari A; Vaidakis D; Bhattacharya S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD006606. PubMed ID: 30480769
[TBL] [Abstract][Full Text] [Related]
8. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
Esinler I; Bayar U; Bozdag G; Yarali H
Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
[TBL] [Abstract][Full Text] [Related]
9. Association between serum AMH levels and IVF/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Yuwen T; Yang Z; Cai G; Feng G; Liu Q; Fu H
Reprod Biol Endocrinol; 2023 Oct; 21(1):95. PubMed ID: 37872575
[TBL] [Abstract][Full Text] [Related]
10. Association of Polycystic Ovary Syndrome Phenotypes With Adverse Pregnancy Outcomes After
Wang Q; Wang H; Li P; Li X; Wang Z; Yan L; Shi Y
Front Endocrinol (Lausanne); 2022; 13():889029. PubMed ID: 35721747
[TBL] [Abstract][Full Text] [Related]
11. Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters.
De Vos M; Pareyn S; Drakopoulos P; Raimundo JM; Anckaert E; Santos-Ribeiro S; Polyzos NP; Tournaye H; Blockeel C
Reprod Biomed Online; 2018 Aug; 37(2):163-171. PubMed ID: 29778554
[TBL] [Abstract][Full Text] [Related]
12. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.
Sahu B; Ozturk O; Ranierri M; Serhal P
Arch Gynecol Obstet; 2008 Mar; 277(3):239-44. PubMed ID: 17899140
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First
Liu S; Mo M; Xiao S; Li L; Hu X; Hong L; Wang L; Lian R; Huang C; Zeng Y; Diao L
Front Endocrinol (Lausanne); 2020; 11():575337. PubMed ID: 33101210
[TBL] [Abstract][Full Text] [Related]
14. The influence of polycystic ovary syndrome on abortion rate after in vitro fertilization/intracytoplasmic sperm injection fresh cycle pregnancy.
Dou Q; Ma LY; Li PF; Xu XT; Yu G; Zhang D; Xiang YG; Tan L
Sci Rep; 2023 Apr; 13(1):5978. PubMed ID: 37045897
[TBL] [Abstract][Full Text] [Related]
15. Inositol for subfertile women with polycystic ovary syndrome.
Showell MG; Mackenzie-Proctor R; Jordan V; Hodgson R; Farquhar C
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012378. PubMed ID: 30570133
[TBL] [Abstract][Full Text] [Related]
16. Infertile polycystic ovary syndrome patients undergoing in vitro fertilization with the gonadotropin-releasing hormone-antagonist protocol: role of hyperandrogenism.
Yang W; Yang R; Yang S; Li J; Tu B; Gao C; Wang Y
Gynecol Endocrinol; 2018 Aug; 34(8):715-718. PubMed ID: 29376451
[TBL] [Abstract][Full Text] [Related]
17. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.
Guo Y; Liu S; Hu S; Li F; Jin L
Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of acupuncture in women with polycystic ovarian syndrome undergoing in vitro fertilisation or intracytoplasmic sperm injection: a systematic review and meta-analysis.
Jo J; Lee YJ
Acupunct Med; 2017 Jun; 35(3):162-170. PubMed ID: 28077366
[TBL] [Abstract][Full Text] [Related]
19. South Asian women with polycystic ovary syndrome exhibit greater sensitivity to gonadotropin stimulation with reduced fertilization and ongoing pregnancy rates than their Caucasian counterparts.
Palep-Singh M; Picton HM; Vrotsou K; Maruthini D; Balen AH
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):202-7. PubMed ID: 17367914
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome phenotype does not have impact on oocyte morphology.
Uk A; Decanter C; Grysole C; Keller L; Béhal H; Silva M; Dewailly D; Robin G; Barbotin AL
Reprod Biol Endocrinol; 2022 Jan; 20(1):7. PubMed ID: 34986863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
